Amgen AMGN reported fourth-quarter 2025 adjusted earnings of $5.29 per share, which beat the Zacks Consensus Estimate of $4.76 per share. Earnings were relatively flat year over year as higher ...
Drug treatment of rheumatoid arthritis aims to reduce inflammation, which slows the progression of joint damage. Etanercept is a soluble tumor necrosis factor (TNF) receptor that mops up circulating ...
At first glance, a TNF inhibitor would not be expected to show efficacy after failure of another inhibitor with the same mechanism of action. Evidence has accumulated, however, demonstrating that TNF ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results